| Identification | Back Directory | [Name]
5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone | [CAS]
548-76-5 | [Synonyms]
Rrigenin
5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one
5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone
5,7-Dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one
4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy- | [EINECS(EC#)]
208-958-3 | [Molecular Formula]
C18H16O8 | [MDL Number]
MFCD00597047 | [MOL File]
548-76-5.mol | [Molecular Weight]
360.31 |
| Chemical Properties | Back Directory | [Melting point ]
189-192℃ | [Boiling point ]
646.1±55.0 °C(Predicted) | [density ]
1.461±0.06 g/cm3 (20 ºC 760 Torr) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Soluble in ethanol and methan | [form ]
powder | [pka]
6.36±0.20(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
Irigenin is identified as an α-glucosidase inhibitors. Also, it is a lead compound to overcome Fibronectin EDA induced metastatic progression in lung carcinoma cells. | [Definition]
ChEBI: A hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3' and methoxy groups at positions 6, 4' and 5' respectively. | [target]
COX | NOS | NAD(P)H:quinone reductase | α-glucosidase | NO | PGE | p65 | NF-κB | [storage]
4°C, protect from light |
|
|